Cargando…

AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis

Background: Progress has been made in genetic investigations on restenosis for the past 20 years, many studies regarding AGTR1 rs5186 polymorphism and restenosis after percutaneous coronary intervention (PCI) have been published, but the result remains controversial. The study aimed to explore the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Feng, Jiang, Yufeng, Wang, Yebao, Zhang, Ting, Zhou, Yafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693694/ https://www.ncbi.nlm.nih.gov/pubmed/36421941 http://dx.doi.org/10.3390/jcdd9110406

Ejemplares similares

Association of AGTR1 (rs5186), VDR (rs2228570) genes polymorphism with blood pressure elevation in patients with essential arterial hypertension
por: Semianiv, Marianna Mykolaivna, et al.
Publicado: (2021)

Allele С (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population
por: Izmailova, O., et al.
Publicado: (2022)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
por: Meier, Pascal, et al.
Publicado: (2012)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis
por: Zhang, Ming-Ming, et al.
Publicado: (2016)

The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis
por: Pleva, L., et al.
Publicado: (2015)

Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis
por: Liu, Yijie, et al.
Publicado: (2023)

Effects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Liu, Jichen, et al.
Publicado: (2015)

AGTR2 and sprint/power performance: a case-control replication study for rs11091046 polymorphism in two ethnicities
por: Yvert, Thomas P., et al.
Publicado: (2017)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
por: Elbadawi, Ayman, et al.
Publicado: (2023)

Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
por: Zholdybayeva, Elena V., et al.
Publicado: (2016)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
por: Joo, Hyung Joon, et al.
Publicado: (2018)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Risk factors associated with intra-stent restenosis after percutaneous coronary intervention
por: Alexandrescu, Dan-Mihai, et al.
Publicado: (2021)

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways
por: Pelliccia, Francesco, et al.
Publicado: (2023)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
por: Hou, Ling, et al.
Publicado: (2023)

Association and Interaction Effect of AGTR1 and AGTR2 Gene Polymorphisms with Dietary Pattern on Metabolic Risk Factors of Cardiovascular Disease in Malaysian Adults
por: Yap, Roseline Wai Kuan, et al.
Publicado: (2017)

AGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population
por: Liu, Yang, et al.
Publicado: (2016)

The role of cytochrome P450 gene rs1126742 polymorphism and risk of hypertension: a systematic review and meta-analysis
por: Huang, Ziyin, et al.
Publicado: (2020)

Percutaneous Coronary Intervention Outcomes in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Khandait, Harshwardhan, et al.
Publicado: (2023)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Calculating the overall risk of within-stent restenosis after multilesion percutaneous coronary intervention
por: Parviz, Yasir, et al.
Publicado: (2013)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention: Retraction
Publicado: (2020)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
por: Guo, Jiqiang, et al.
Publicado: (2022)

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
por: Zheng, Guo-Hua, et al.
Publicado: (2012)

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
por: Prskalo, Zrinko, et al.
Publicado: (2016)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
por: Lv, Lizhi, et al.
Publicado: (2019)

Comparison of Six Different Percutaneous Coronary Intervention Guidance Modalities
por: Hu, Mengjin, et al.
Publicado: (2022)

The effectiveness of Salvianolate injection for in-stent restenosis after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhang, Miao, et al.
Publicado: (2022)

Blood pressure, arterial stiffness and endogenous lithium clearance in relation to AGTR1 A1166C and AGTR2 G1675A gene polymorphisms
por: Cwynar, Marcin, et al.
Publicado: (2016)

The relationship between procedural volume and patient outcomes for percutaneous coronary interventions: a systematic review and meta-analysis
por: Walsh, Kieran A., et al.
Publicado: (2021)

The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus
por: Lexis, Chris PH, et al.
Publicado: (2009)

The Predictive Value of ΣΔST/ΔHR Index for Restenosis after Percutaneous Coronary Intervention
por: Kim, Chul, et al.
Publicado: (2012)

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
por: Kullmann, Silke, et al.
Publicado: (2009)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
por: Zhang, Rui, et al.
Publicado: (2022)

Influence of AGTR1 and ABCB1 Gene Polymorphism on the Curative Effect of Irbesartan
por: Wang, Qiao, et al.
Publicado: (2022)

Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
por: Zhao, Shi-jie, et al.
Publicado: (2016)

Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Zhu, Decai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tdgl4eg6rieu7rfflj9hgefmq1